MD Anderson was awarded nine grants from the CPRIT
Peter Pisters shared a post by MD Anderson Cancer Center on LinkedIn, adding:
“We are enormously appreciative of Cancer Prevention and Research Institute of Texas’ support of MD Anderson Cancer Center’s impactful initiatives that will help advance important areas of cancer research. The work by our world-class scientists and clinicians reflects their unwavering commitment to our goal to End Cancer.”
Quoting MD Anderson Cancer Center’s post:
“Today, MD Anderson was awarded nine grants totaling over $21.4 million from the Cancer Prevention and Research Institute of Texas in support of two new core facilities, faculty recruitment and groundbreaking cancer research across all areas of the institution.
‘We are enormously appreciative of CPRIT’s support of impactful cancer research initiatives at MD Anderson,’ says our Dr. Peter Pisters.
Read about it here.”
Source: Peter Pisters/ LinkedIn and MD Anderson Cancer Center/LinkedIn
For more posts about MD Anderson Cancer Center, visit oncodaily.com
Peter Pisters leads The University of Texas MD Anderson Cancer Center, driving research across various fields including oncology, cardiology, transplantation, neurosciences, surgical innovation, infectious diseases, genomic medicine, and rehabilitation medicine.
He contributes to academic journals such as the Journal of Clinical Oncology and Surgery and reviews for several publications. His research focuses on sarcomas, GI cancers, and other malignancies.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023